Protective effects of Helicobacter pylori for IBD are related to the cagA- positive strain

A R Lord¹, L A Simms¹, K Hanigan¹, R Sullivan², P Hobson³, G L Radford-Smith^{1

4

5}

Affiliations

¹ Inflammatory Bowel Diseases, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
² Abacus ALS, Auckland, New Zealand.
³ Immunology/Serology, Sullivan Nicolaides Pathology, Brisbane, Australia.
⁴ Department of Gastroenterology, Royal Brisbane and Women's Hospital, Brisbane, Australia.
⁵ University of Queensland School of Medicine, Herston Campus, Brisbane, Australia.

Comment

A R Lord et al. Gut. 2018 Feb.

. 2018 Feb;67(2):393-394.

doi: 10.1136/gutjnl-2017-313805. Epub 2017 Apr 13.

A R Lord¹, L A Simms¹, K Hanigan¹, R Sullivan², P Hobson³, G L Radford-Smith^{1

4

5}

¹ Inflammatory Bowel Diseases, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
² Abacus ALS, Auckland, New Zealand.
³ Immunology/Serology, Sullivan Nicolaides Pathology, Brisbane, Australia.
⁴ Department of Gastroenterology, Royal Brisbane and Women's Hospital, Brisbane, Australia.
⁵ University of Queensland School of Medicine, Herston Campus, Brisbane, Australia.

No abstract available

Keywords: CROHN'S DISEASE; IBD; ULCERATIVE COLITIS.

Conflict of interest statement

Competing interests: None declared.

Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis.
Castaño-Rodríguez N, Kaakoush NO, Lee WS, Mitchell HM. Castaño-Rodríguez N, et al. Gut. 2017 Feb;66(2):235-249. doi: 10.1136/gutjnl-2015-310545. Epub 2015 Oct 27. Gut. 2017. PMID: 26508508